Skip to main content
Erschienen in: World Journal of Urology 1/2020

16.04.2019 | Original Article

Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage

verfasst von: Michael Baboudjian, Khalid Al-Balushi, Floriane Michel, Francois Lannes, Akram Akiki, Sarah Gaillet, Veronique Delaporte, Evelyne Ragni, Harry Toledano, Gilles Karsenty, Dominique Rossi, Cyrille Bastide, Eric Lechevallier, Romain Boissier

Erschienen in: World Journal of Urology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

There have recent reports in the literature of increased rates of bladder recurrence (BR) after radical nephroureterectomy (RNU) when diagnostic flexible ureteroscopy (DFU) was performed before RNU. The technical heterogeneity of DFU was a major bias in these studies. Our purpose was to evaluate the impact of a standardized DFU technique before RNU on the risk of BR.

Methods

A retrospective monocenter study including patients who underwent RNU for upper tract urothelial carcinoma (UTUC) between 2005 and 2017. 171 patients were identified. 78 patients were excluded owing to a history of bladder cancer before RNU or neo-adjuvant/adjuvant chemotherapy. 93 included patients were stratified according to pre-RNU ureteroscopy (DFU + 70 patients) or no pre-RNU ureteroscopy (DFU—23 patients). The standardized DFU technique consisted of systematic ureteral sheath (ch9–10), flexible ureteroscopy, biopsy, and drainage with a mono-J/bladder catheter to avoid contact of contaminated urine of the upper tract with the bladder.

Results

Epidemiological, initial staging, and postoperative tumoral characteristics were similar in both groups. Mean follow-up was 35 months [2–166], 47(50%) BR occurred with 41(87%) in the DFU + group, and pre-RNU–DFU was an independent predictive factor of BR (OR = 4[1.4–11.9], P = 0.01) (Cox regression model). The characteristics of BR were similar in both groups, although BR occurred earlier in DFU + (427 days vs. 226 days (P = 0.07)).

Conclusion

Bladder recurrence after diagnostic ureteroscopy + nephroureterectomy was high despite technical precautions to avoid contact of bladder mucosa with contaminated urine from the upper urinary tract. Post-DFU endovesical instillation should be investigated.
Literatur
1.
Zurück zum Zitat Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BWG, Compérat E et al (2013) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64(4):639–653CrossRef Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BWG, Compérat E et al (2013) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64(4):639–653CrossRef
2.
Zurück zum Zitat Seisen T, Peyronnet B, Dominguez-Escrig JL, Bruins HM, Yuan CY, Babjuk M et al (2016) Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the eau non-muscle invasive bladder cancer guidelines panel. Eur Urol 70(6):1052–1068CrossRef Seisen T, Peyronnet B, Dominguez-Escrig JL, Bruins HM, Yuan CY, Babjuk M et al (2016) Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the eau non-muscle invasive bladder cancer guidelines panel. Eur Urol 70(6):1052–1068CrossRef
3.
Zurück zum Zitat Marchioni M, Primiceri G, Cindolo L, Hampton LJ, Grob MB, Guruli G et al (2017) Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis. BJU Int 120(3):313–319CrossRef Marchioni M, Primiceri G, Cindolo L, Hampton LJ, Grob MB, Guruli G et al (2017) Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis. BJU Int 120(3):313–319CrossRef
4.
Zurück zum Zitat Guo R-Q, Hong P, Xiong G-Y, Zhang L, Fang D, Li X-S et al (2018) Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis. BJU Int 121(2):184–193CrossRef Guo R-Q, Hong P, Xiong G-Y, Zhang L, Fang D, Li X-S et al (2018) Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis. BJU Int 121(2):184–193CrossRef
5.
Zurück zum Zitat Seisen T, Granger B, Colin P, Léon P, Utard G, Renard-Penna R et al (2015) A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol 67(6):1122–1133CrossRef Seisen T, Granger B, Colin P, Léon P, Utard G, Renard-Penna R et al (2015) A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol 67(6):1122–1133CrossRef
6.
Zurück zum Zitat O’Brien T, Ray E, Singh R, Coker B, Beard R, British Association of Urological Surgeons Section of Oncology (2011) Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C trial). Eur Urol 60(4):703–710CrossRef O’Brien T, Ray E, Singh R, Coker B, Beard R, British Association of Urological Surgeons Section of Oncology (2011) Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C trial). Eur Urol 60(4):703–710CrossRef
7.
Zurück zum Zitat Ito A, Shintaku I, Satoh M, Ioritani N, Aizawa M, Tochigi T et al (2013) Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol Off J Am Soc Clin Oncol. 31(11):1422–1427CrossRef Ito A, Shintaku I, Satoh M, Ioritani N, Aizawa M, Tochigi T et al (2013) Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol Off J Am Soc Clin Oncol. 31(11):1422–1427CrossRef
8.
Zurück zum Zitat Hendin BN, Streem SB, Levin HS, Klein EA, Novick AC (1999) Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma. J Urol 161(3):783–785CrossRef Hendin BN, Streem SB, Levin HS, Klein EA, Novick AC (1999) Impact of diagnostic ureteroscopy on long-term survival in patients with upper tract transitional cell carcinoma. J Urol 161(3):783–785CrossRef
9.
Zurück zum Zitat Ishikawa S, Abe T, Shinohara N, Harabayashi T, Sazawa A, Maruyama S et al (2010) Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract. J Urol 184(3):883–887CrossRef Ishikawa S, Abe T, Shinohara N, Harabayashi T, Sazawa A, Maruyama S et al (2010) Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract. J Urol 184(3):883–887CrossRef
10.
Zurück zum Zitat Gurbuz C, Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI et al (2011) The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma. J Endourol 25(5):775–779CrossRef Gurbuz C, Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI et al (2011) The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma. J Endourol 25(5):775–779CrossRef
11.
Zurück zum Zitat Luo HL, Kang CH, Chen YT, Chuang YC, Lee WC, Cheng YT et al (2013) Diagnostic ureteroscopy independently correlates with intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. Ann Surg Oncol 20(9):3121–3126CrossRef Luo HL, Kang CH, Chen YT, Chuang YC, Lee WC, Cheng YT et al (2013) Diagnostic ureteroscopy independently correlates with intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. Ann Surg Oncol 20(9):3121–3126CrossRef
12.
Zurück zum Zitat Nison L, Rouprêt M, Bozzini G, Ouzzane A, Audenet F, Pignot G et al (2013) The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database. World J Urol 31(1):69–76CrossRef Nison L, Rouprêt M, Bozzini G, Ouzzane A, Audenet F, Pignot G et al (2013) The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database. World J Urol 31(1):69–76CrossRef
13.
Zurück zum Zitat Sung HH, Jeon HG, Han DH, Jeong BC, Seo SI, Lee HM et al (2015) Diagnostic ureterorenoscopy is associated with increased intravesical recurrence following radical nephroureterectomy in upper tract urothelial carcinoma. PLoS One 10(11):e0139976CrossRef Sung HH, Jeon HG, Han DH, Jeong BC, Seo SI, Lee HM et al (2015) Diagnostic ureterorenoscopy is associated with increased intravesical recurrence following radical nephroureterectomy in upper tract urothelial carcinoma. PLoS One 10(11):e0139976CrossRef
14.
Zurück zum Zitat Liu P, Su X-H, Xiong G-Y, Li X-S, Zhou L-Q (2016) Diagnostic ureteroscopy for upper tract urothelial carcinoma is independently associated with intravesical recurrence after radical nephroureterectomy. Int Braz J Urol Off J Braz Soc Urol 42(6):1129–1135CrossRef Liu P, Su X-H, Xiong G-Y, Li X-S, Zhou L-Q (2016) Diagnostic ureteroscopy for upper tract urothelial carcinoma is independently associated with intravesical recurrence after radical nephroureterectomy. Int Braz J Urol Off J Braz Soc Urol 42(6):1129–1135CrossRef
15.
Zurück zum Zitat Sankin A, Tin AL, Mano R, Chevinsky M, Jakubowski C, Sfakianos JP et al (2016) Impact of ureteroscopy before nephroureterectomy for upper tract urothelial carcinoma on oncologic outcomes. Urology 94:148–153CrossRef Sankin A, Tin AL, Mano R, Chevinsky M, Jakubowski C, Sfakianos JP et al (2016) Impact of ureteroscopy before nephroureterectomy for upper tract urothelial carcinoma on oncologic outcomes. Urology 94:148–153CrossRef
16.
Zurück zum Zitat Lim DJ, Shattuck MC, Cook WA (1993) Pyelovenous lymphatic migration of transitional cell carcinoma following flexible ureterorenoscopy. J Urol 149(1):109–111CrossRef Lim DJ, Shattuck MC, Cook WA (1993) Pyelovenous lymphatic migration of transitional cell carcinoma following flexible ureterorenoscopy. J Urol 149(1):109–111CrossRef
17.
Zurück zum Zitat Kulp DA, Bagley DH (1994) Does flexible ureteropyeloscopy promote local recurrence of transitional cell carcinoma? J Endourol 8(2):111–113CrossRef Kulp DA, Bagley DH (1994) Does flexible ureteropyeloscopy promote local recurrence of transitional cell carcinoma? J Endourol 8(2):111–113CrossRef
18.
Zurück zum Zitat Lee JK, Kim KB, Park YH, Oh JJ, Lee S, Jeong CW et al (2016) Correlation between the timing of diagnostic ureteroscopy and intravesical recurrence in upper tract urothelial cancer. Clin Genitourin Cancer 14(1):e37–e41CrossRef Lee JK, Kim KB, Park YH, Oh JJ, Lee S, Jeong CW et al (2016) Correlation between the timing of diagnostic ureteroscopy and intravesical recurrence in upper tract urothelial cancer. Clin Genitourin Cancer 14(1):e37–e41CrossRef
19.
Zurück zum Zitat Yoo S, You D, Song C, Hong B, Hong JH, Kim C-S et al (2017) Risk of intravesical recurrence after ureteroscopic biopsy for upper tract urothelial carcinoma: does the location matter? J Endourol 31(3):259–265CrossRef Yoo S, You D, Song C, Hong B, Hong JH, Kim C-S et al (2017) Risk of intravesical recurrence after ureteroscopic biopsy for upper tract urothelial carcinoma: does the location matter? J Endourol 31(3):259–265CrossRef
20.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67(1):7–30CrossRef Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67(1):7–30CrossRef
21.
Zurück zum Zitat Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH (2012) High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology 79(3):615–619CrossRef Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH (2012) High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology 79(3):615–619CrossRef
22.
Zurück zum Zitat Margolin EJ, Matulay JT, Li G, Meng X, Chao B, Vijay V et al (2018) Discordance between ureteroscopic biopsy and final pathology for upper tract urothelial carcinoma. J Urol 199(6):1440–1445CrossRef Margolin EJ, Matulay JT, Li G, Meng X, Chao B, Vijay V et al (2018) Discordance between ureteroscopic biopsy and final pathology for upper tract urothelial carcinoma. J Urol 199(6):1440–1445CrossRef
23.
Zurück zum Zitat Smith AK, Stephenson AJ, Lane BR, Larson BT, Thomas AA, Gong MC et al (2011) Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology 78(1):82–86CrossRef Smith AK, Stephenson AJ, Lane BR, Larson BT, Thomas AA, Gong MC et al (2011) Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology 78(1):82–86CrossRef
Metadaten
Titel
Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage
verfasst von
Michael Baboudjian
Khalid Al-Balushi
Floriane Michel
Francois Lannes
Akram Akiki
Sarah Gaillet
Veronique Delaporte
Evelyne Ragni
Harry Toledano
Gilles Karsenty
Dominique Rossi
Cyrille Bastide
Eric Lechevallier
Romain Boissier
Publikationsdatum
16.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 1/2020
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02768-w

Weitere Artikel der Ausgabe 1/2020

World Journal of Urology 1/2020 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.